[go: up one dir, main page]

AU2003269483A1 - Phosphoric acid salt of 5-((4-(2-(methyl-2-pyridinylamino) ethoxy) phenyl) methyl)- 2,4-thiazolidinedione - Google Patents

Phosphoric acid salt of 5-((4-(2-(methyl-2-pyridinylamino) ethoxy) phenyl) methyl)- 2,4-thiazolidinedione

Info

Publication number
AU2003269483A1
AU2003269483A1 AU2003269483A AU2003269483A AU2003269483A1 AU 2003269483 A1 AU2003269483 A1 AU 2003269483A1 AU 2003269483 A AU2003269483 A AU 2003269483A AU 2003269483 A AU2003269483 A AU 2003269483A AU 2003269483 A1 AU2003269483 A1 AU 2003269483A1
Authority
AU
Australia
Prior art keywords
methyl
pyridinylamino
thiazolidinedione
ethoxy
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003269483A
Inventor
Sambasivam Ganesh
Tom Thomas Puthiaparampil
Sumitra Srinath
Sandhya Ujire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocon Ltd
Original Assignee
Biocon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Ltd filed Critical Biocon Ltd
Publication of AU2003269483A1 publication Critical patent/AU2003269483A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003269483A 2003-09-10 2003-09-10 Phosphoric acid salt of 5-((4-(2-(methyl-2-pyridinylamino) ethoxy) phenyl) methyl)- 2,4-thiazolidinedione Abandoned AU2003269483A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000306 WO2005023803A1 (en) 2003-09-10 2003-09-10 Phosphoric acid salt of 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl] methyl]- 2,4-thiazolidinedione

Publications (1)

Publication Number Publication Date
AU2003269483A1 true AU2003269483A1 (en) 2005-03-29

Family

ID=34259921

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003269483A Abandoned AU2003269483A1 (en) 2003-09-10 2003-09-10 Phosphoric acid salt of 5-((4-(2-(methyl-2-pyridinylamino) ethoxy) phenyl) methyl)- 2,4-thiazolidinedione

Country Status (2)

Country Link
AU (1) AU2003269483A1 (en)
WO (1) WO2005023803A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR047541A1 (en) * 2004-02-13 2006-01-25 Sandoz Ag PHOSPHATE OF 5 - [[4- [2-METHYL-2-PYRIDINYL-AMINO-ETOXI] PHENYL] METHYL] -2,4 THYZOLIDINADION (ROSIGLITAZONE) AND ITS POLYMORPHIC FORMS
CZ296468B6 (en) * 2004-06-10 2006-03-15 Zentiva, A. S. Salt of phosphoric acid with 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and process for its preparation
CZ298424B6 (en) * 2005-05-24 2007-09-26 Zentiva, A. S. Crystallization process of rosiglitazone and derivatives thereof from mixed solutions
DE102005034406A1 (en) * 2005-07-22 2007-02-01 Ratiopharm Gmbh New salts of rosiglitazone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306228B1 (en) * 1987-09-04 1999-11-17 Beecham Group Plc Substituted thiazolidinedione derivatives
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
WO2002051823A1 (en) * 2000-12-26 2002-07-04 Torrent Pharmaceuticals Ltd Process for the preparation of rosiglitazone maleate
EP1446404B1 (en) * 2001-11-21 2006-06-14 Smithkline Beecham Plc Rosiglitazone edisylates and their use as antidiabetics

Also Published As

Publication number Publication date
WO2005023803A1 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
EP1954683A4 (en) 2- (PHENYL OR HETEROCYCLIC) -1H-PHENANTRHO (9,10-D) IMIDAZOLES AS INHIBITORS OF MPGES-1
IL182647A0 (en) An oral preparation having improved bioavailability
WO2009025983A3 (en) Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
CL2008002142A1 (en) Compounds derived from 2-amino-6 - ({[2- (4-chlorophenyl) -1,3-thiazol-4-yl] methyl} thio) -4- [4- (2-hydroxyethoxy) phenyl] pyridin-3 , 5-dicarbonitrile; preparation procedure; Pharmaceutical composition and use in cardiovascular diseases.
EP1828143A4 (en) 1H-PHENANTHRO [9,10-D] IMIDAZOLES SUBSTITUTED INTO 2 BY PHENYL OR HETEROCYCLE AS INHIBITORS OF MPGES-1
CL2007003459A1 (en) PREPARATION PROCESS OF COMPOUNDS DERIVED FROM PYRIMIDINE; AND INTERMEDIARY COMPOUND (S) -TRANS-ETIL 3-ETOXI-7- (4- (4-FLUOROPHENIL) -6-ISOPROPIL-2- (N-METHYLMETHYLPHONAMIDE) PIRIMIDIN-5-IL) -5-HYDROXIHEP-2,6 - DIENOATE.
WO2005080358A3 (en) Rosiglitazone phosphate and polymorphic forms
AU2002313655A1 (en) 2-(5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl)-succinic acid derivatives as factor viia inhibitors
WO2005105096A3 (en) Fused heterocyclic compounds
UA92354C2 (en) Amino acid salts of rosiglitazone
AU2003269483A1 (en) Phosphoric acid salt of 5-((4-(2-(methyl-2-pyridinylamino) ethoxy) phenyl) methyl)- 2,4-thiazolidinedione
AU2003269479A1 (en) Phosphoric acid salt of 5-((4-(2-(5-ethyl-2-pyridinyl) ethoxy) phenyl) methyl)-2, 4-thiazolidinedione
AU2003215158A1 (en) 2-(5-(5-carbamimidoyl-1h-heteroaryl))-6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
EP1773307B8 (en) Compound formulations of 2-amino-1,3-propanediol compounds
AU2003260813A1 (en) Improved process for preparation of thiazolidinedione derivatives
AU2003235814A1 (en) Novel process for the preparation of trans-3- ethyl-2,5- dihydro-4- methyl-n-(2-( 4-(((((4-methyl cyclohexyl) amino)carbonyl) amino)sulfonyl) phenyl)ethyl) -2-oxo-1h-pyrrole -1-carboxamide
CL2004001123A1 (en) SOLID FORMS OF SODIUM COMPLEXES OF 5- (DIFLUOROMETOXI) -2 - [[3,4-DIMETOXI-2-PIRIDINIL) METHYL] SULFINIL] -1H-BENZOIMIDAZOL (PANTOPREZOL) AQUOUS, PHARMACEUTICAL COMPOSITION FOR PREPARATION PROCEDURE OR PREPARATION PROCEDURE FORMS OF PANTOPREZOL YP
JP2003335680A5 (en)
WO2006079923A3 (en) Form iv crystalline celecoxib
NO20053431D0 (en) New crystalline modification of 2- (3,5-bis-trifluoromethyl-phenyl) -N- (6- (1,1-dioxo-1gamma6-thiomorpholin-4-yl) -4 (4-fluoro-2-methyl-phenyl) ) -pyridin-3-yl) -N-methyl-isobutyramide.
AU2001290743A1 (en) Solid salt forms of n-(2-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)ethyl)-2-oxo-1-piperidineacetamide
WO2007130064A8 (en) 2-n-(5-[[4-(2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
AU2006317419B2 (en) 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
WO2008010089A3 (en) Process for preparation of intermediates of rosiglitazone, rosiglitazone and polymorphic forms thereof
WO2000042014A3 (en) 1-(6- methylpyridine- 3-yl)-2-[4- (methylsulfonyl) phenyl] ethanone and method for its preparation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase